Pemirolast Potassium

吡嘧司特钾

Report date: 2022/01/14 13:23:58
NMEFirst In Class

Base Information

Drug NamePemirolast Potassium
Drug Alias Name普利敏钾哌罗来斯钾PemilastonAlamastAlegysal +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMediator release inhibitorsLeukotriene inhibitors
TargetsLeukotriene
Therapy Area/IndicationsConjunctivitis, AllergicConjunctivitisRhinitis, Allergic +[4] 
Global Approved IndicationsConjunctivitis, AllergicConjunctivitisRhinitis, Allergic +[4] 
Approved Indications in ChinaConjunctivitis, AllergicRhinitis, Allergic
Original Approved Country/TerritoryJapan
Original Approved Date1981/01/18
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlfresa Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAlfresa PharmaSanten
Inactive CompaniesSanten Inc
Active IndicationsConjunctivitis, AllergicConjunctivitisRhinitis, Allergic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeR
Related LinksWikipediaDrugBankKEGG